Abstract
Recently, a new form of autosomal recessive early-onset parkinsonism (PARK20), due to mutations in the gene encoding the phosphoinositide phosphatase, Synaptojanin 1 (Synj1), has been reported. Several genes responsible for hereditary forms of Parkinson’s disease are implicated in distinct steps of the endolysosomal pathway. However, the nature and the degree of endocytic membrane trafficking impairment in early-onset parkinsonism remains elusive. Here, we show that depletion of Synj1 causes drastic alterations of early endosomes, which become enlarged and more numerous, while it does not affect the morphology of late endosomes both in non-neuronal and neuronal cells. Moreover, Synj1 loss impairs the recycling of transferrin, while it does not alter the trafficking of the epidermal growth factor receptor. The ectopic expression of Synj1 restores the functions of early endosomes, and rescues these trafficking defects in depleted cells. Importantly, the same alterations of early endosomal compartments and trafficking defects occur in fibroblasts of PARK20 patients. Our data indicate that Synj1 plays a crucial role in regulating the homeostasis and functions of early endosomal compartments in different cell types, and highlight defective cellular pathways in PARK20. In addition, they strengthen the link between endosomal trafficking and Parkinson’s disease.
Highlights
Synaptojanin 1 (Synj1) is an inositol-phosphatase belonging to the family of Sac domain-containing proteins[1,2]
As revealed by the EEA1 antibody, the EEs increased in both number and size in HeLa (Figs. 2a-e) and SH-SY5Y (Figs. 2l-o) Synj1i cells when compared with EEs in Ctli cells
Silenced HeLa cells displayed numerous EEA1-positive tubular structures (Figs. 2f-h), and the percentage of cells containing these structures was drastically higher in Synj1i than in Ctli cells (Fig. 2i)
Summary
Synaptojanin 1 (Synj1) is an inositol-phosphatase belonging to the family of Sac domain-containing proteins[1,2]. 90% of PD cases are idiopathic, at least 10% are inherited, and several causative genes have been identified[13,14,15]. Fasano et al Cell Death and Disease (2018)9:385 diverse set of proteins, many of them are implicated in several steps of the endolysosomal pathway[14,16]. Mutations in the Synj[1] gene have been reported to be associated with PARK2017–19. Afterwards, a novel homozygous mutation (c.1376C>G, p.R459P) in Synj[1] was identified in an Indian family[20]. Both mutations are in the Sac[1] domain. R258Q has been reported to abolish both 3- and 4-phosphatase activities, and do not affect the activity on PI(4,5)P218
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.